Home › Squamous Cell Carcinoma
Pag-aaral pangklinika para sa Squamous Cell Carcinoma na nagre-recruit sa U.S.
56 pag-aaral para sa Squamous Cell Carcinoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Pittsburgh, PA11 pag-aaral
- Los Angeles, CA9 pag-aaral
- Nashville, TN8 pag-aaral
- New York City, NY7 pag-aaral
- Boston, MA7 pag-aaral
- Houston, TX7 pag-aaral
- Durham, NC6 pag-aaral
- St. Louis, MO6 pag-aaral
- San Diego, CA6 pag-aaral
- Chicago, IL5 pag-aaral
- Queens, NY4 pag-aaral
- Washington, DC4 pag-aaral
- Orlando, FL4 pag-aaral
- Atlanta, GA4 pag-aaral
- Tampa, FL4 pag-aaral
- Staten Island, NY3 pag-aaral
- Dallas, TX3 pag-aaral
- Philadelphia, PA3 pag-aaral
- Charleston, SC3 pag-aaral
- Baltimore, MD3 pag-aaral
- Rochester, NY3 pag-aaral
- Arlington, VA3 pag-aaral
- Indianapolis, IN3 pag-aaral
Ayos sa estado
- California13 pag-aaral
- Florida13 pag-aaral
- Georgia4 pag-aaral
- Illinois5 pag-aaral
- Indiana3 pag-aaral
- Kentucky3 pag-aaral
- Maryland4 pag-aaral
- Massachusetts7 pag-aaral
- Michigan3 pag-aaral
- Minnesota3 pag-aaral
- Missouri6 pag-aaral
- New Jersey3 pag-aaral
- New York15 pag-aaral
- North Carolina7 pag-aaral
- Ohio4 pag-aaral
- Pennsylvania14 pag-aaral
- South Carolina4 pag-aaral
- Tennessee9 pag-aaral
- Texas12 pag-aaral
- Virginia6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT02507141Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07741643Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07631013Evaluating Photodynamic Therapy Used to Treat Cutaneous Squamous Cell Carcinoma in Situ (isSCC) on the Face, Upper Extremities & Trunk.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07931664Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07741565Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT04198766JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Nagre-recruitPhase 3
Edad 60 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT04892173Basal Cell Carcinoma Chemoprevention Trial
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT05212246Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07901959Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06295731Intratumoral N17350 in Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07339176T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 72 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT02133196PDT For Induction Therapy For Head And Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07214987Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07460765Cemiplimab and Quad Shot Radiation for Cutaneous Squamous Cell Carcinoma in the Head and Neck
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07869823A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07115043Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT04429542The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07285044Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06736379Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05027633Effects of Infusion Timing on Treatment Response in Solid Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07630168Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07513389A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07602842Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04915183Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.